Further, microbiota-specific CD4+ T cells in patients with IBD have been shown to be functionally altered and produce more proinflammatory cytokines such as IL-17, compared with T cells from healthy patients (14, 26–30). This evidence concerns the gene IL17A and inflammatory bowel disease.